ScreenerHero

ABDX Abingdon Health Plc

LSE · GB · Healthcare · Diagnostics & Research · abingdonhealth.com
11.00GBp0.00%Mkt Cap: 30.22M $P/E: —

Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturi…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$250.23BUSDP/E 36.4
DHR
Danaher Corporation
$155.51BUSDP/E 39.4
NTRA
Natera, Inc.
$61.35BUSD
LONN
Lonza Group AG
$45.82BUSDP/E 38.1
A
Agilent Technologies, Inc.
$48.29BUSDP/E 33.8
ILMN
Illumina, Inc.
$44.35BUSDP/E 54.8
IQV
IQVIA Holdings Inc.
$43.80BUSDP/E 33.1
WAT
Waters Corporation
$43.21BUSDP/E 111.4
IDXX
IDEXX Laboratories, Inc.
$41.58BUSDP/E 37.0
MTD
Mettler-Toledo International Inc.
$30.89BUSDP/E 34.7
DGX
Quest Diagnostics Incorporated
$25.63BUSDP/E 24.7
GH
Guardant Health, Inc.
$25.12BUSD
LH
Labcorp Holdings Inc.
$25.03BUSDP/E 25.5
RVTY
Revvity, Inc.
$17.56BUSDP/E 75.3
MEDP
Medpace Holdings, Inc.
$17.32BUSDP/E 36.4
CRL
Charles River Laboratories International, Inc.
$14.84BUSD
ERF
Eurofins Scientific SE
$14.05BUSDP/E 26.2
ICLR
ICON Public Limited Company
$12.99BUSDP/E 177.2
BIM
bioMérieux S.A.
$10.02BUSDP/E 20.0
QGEN
Qiagen N.V.
$9.46BUSDP/E 23.2

Key Statistics

Company
Market Cap30.22M USD
Enterprise Value48.82M USD
Revenue (TTM)10.40M USD
Gross Profit4.06M USD
Net Income (TTM)-3.71M USD
Revenue/Share0.03 GBp
Last Price11.00 GBp
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees129
CountryGB
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)220.00
PEG—
EV/EBITDA-13.13
EV/Revenue4.69
P/S2.90
P/B7.33
EPS (TTM)-0.01
EPS (Forward)0.00
52W Range
0.000085% of range13.00
52W High13.00 GBp
52W Low0.0000 GBp
Profitability
Gross Margin44.32%
Oper. Margin-53.88%
EBITDA Margin-35.73%
Profit Margin-40.51%
ROE-64.43%
ROA-36.67%
Growth
Revenue Growth36.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.46M USD
CapEx (TTM)376.09K USD
FCF Margin-15.34%
FCF Yield-5.28%
Net Debt-3.00M USD
Net Debt/EBITDA0.81
Balance Sheet
Debt/Equity0.19
Current Ratio1.91
Quick Ratio1.73
Book Value/Sh0.01 GBp
Cash/Share0.0090 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 GBp
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)19.00 GBp
Upside (mean)+72.7%
Target Range19.00 GBp – 19.00 GBp
# Analysts1
Ownership
Shares Out.252.75M
Float168.65M
Insiders30.43%
Institutions31.57%
Technical
SMA 5010.65 (+3.3%)
SMA 2009.250 (+18.9%)
Beta0.14
S&P 52W Chg14.58%
Avg Vol (30d)97.79K
Avg Vol (10d)121.58K
Technical Indicators
RSI (14)64.8
MACD0.0852
MACD Signal0.0436
MACD Hist.+0.0417
BB Upper11.21 GBp
BB Middle10.74 GBp
BB Lower10.27 GBp
BB Width8.80%
ATR (14)0.9303 GBp
Vol Ratio (20d)1.25x